Monday, March 07, 2005

Pharmed ups production capacity for booming joint health ingredient (VIOXX)

"07/03/2005 - Indian glucosamine supplier Pharmed Medicare started production at a new facility near Banaglore last week, adding a further 500 tons in yearly capacity for the firm, reports Dominique Patton.

European demand for the joint health supplement is growing at between 10 and 15 per cent, estimates Pharmed president Sundeep Aurora.

The company, which claims to supply around 70 per cent of Europe’s glucosamine market, currently produces around 1,000 tons per year.

A current shortage of the main raw material required to make the ingredient – the chitin fibre found in shrimp and crab shells - has recently trebled costs for the company and will restrict full scale-up of the plant in the current year." (Read here for more)

0 Comments:

Post a Comment

<< Home